BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 12734137)

  • 1. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
    DeWitt DE; Hirsch IB
    JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
    Kinsley B
    Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled dry powder insulin for the treatment of diabetes mellitus.
    Setter SM; Levien TL; Iltz JL; Odegard PS; Neumiller JJ; Baker DE; Campbell RK
    Clin Ther; 2007 May; 29(5):795-813. PubMed ID: 17697900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
    Duckworth W; Davis SN
    J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
    Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
    Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of insulin analogues for diabetes mellitus.
    Cameron CG; Bennett HA
    CMAJ; 2009 Feb; 180(4):400-7. PubMed ID: 19221353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
    Alemzadeh R; Berhe T; Wyatt DT
    Pediatrics; 2005 May; 115(5):1320-4. PubMed ID: 15867042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.
    Garg S; Ampudia-Blasco FJ; Pfohl M
    Endocr Pract; 2010; 16(3):486-505. PubMed ID: 20150026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with insulin glargine in type 1 diabetes.
    Garg S; Moser E; Dain MP; Rodionova A
    Diabetes Technol Ther; 2010 Nov; 12(11):835-46. PubMed ID: 20969435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy in type 2 diabetes: what is the evidence?
    van Avendonk MJ; Rutten GE
    Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.
    DeWitt DE; Dugdale DC
    JAMA; 2003 May; 289(17):2265-9. PubMed ID: 12734138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin glargine.
    Campbell RK; White JR; Levien T; Baker D
    Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
    Danne T
    Clin Ther; 2007; 29 Suppl D():S145-52. PubMed ID: 18191066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrative review: a rational approach to starting insulin therapy.
    Mooradian AD; Bernbaum M; Albert SG
    Ann Intern Med; 2006 Jul; 145(2):125-34. PubMed ID: 16847295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH; Nattrass M; Pieber TR
    Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.